ACADIA Pharmaceuticals Inc (ACAD) Insider Trading
- $578,210,290.42
- $98,756,635.53
- Feb. 9, 2026
- Stephen Davis
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 12, 2021 | President | 700 | $55.01 | Sell | $38,507.00 | |
| Jan. 8, 2021 | President | 29,733 | $55.22 | Sell | $1,641,856.26 | |
| Jan. 6, 2021 | EVP | 1,120 | $53.34 | Sell | $59,740.80 | |
| Jan. 6, 2021 | CFO | 1,016 | $53.34 | Sell | $54,193.44 | |
| Jan. 6, 2021 | President | 1,725 | $53.34 | Sell | $92,011.50 | |
| Jan. 6, 2021 | CEO | 3,484 | $53.34 | Sell | $185,836.56 | |
| Nov. 20, 2020 | President | 2,728 | $53.50 | Sell | $145,948.00 | |
| Oct. 27, 2020 | EVP | 8,750 | $45.10 | Sell | $394,625.00 | |
| Oct. 16, 2020 | EVP | 1,247 | $42.56 | Sell | $53,072.32 | |
| Oct. 16, 2020 | President | 1,297 | $42.56 | Sell | $55,200.32 | |
| Oct. 16, 2020 | CEO | 2,960 | $42.56 | Sell | $125,977.60 | |
| July 7, 2020 | EVP | 27,250 | $56.25 | Sell | $1,532,812.50 | |
| June 19, 2020 | President | 82,295 | $50.03 | Sell | $4,117,218.85 | |
| May 13, 2020 | CEO | 111,458 | $46.35 | Sell | $5,166,078.30 | |
| May 11, 2020 | Director | 26,250 | $51.13 | Sell | $1,342,162.50 | |
| April 30, 2020 | CEO | 6,770 | $49.21 | Sell | $333,151.70 | |
| April 30, 2020 | EVP | 1,072 | $49.22 | Sell | $52,763.84 | |
| April 30, 2020 | President | 4,308 | $49.21 | Sell | $211,996.68 | |
| April 29, 2020 | CFO | 10,000 | $50.74 | Sell | $507,400.00 | |
| April 22, 2020 | President | 54,019 | $50.02 | Sell | $2,702,030.38 | |
| April 20, 2020 | President | 100,000 | $50.15 | Sell | $5,015,000.00 | |
| March 18, 2020 | Director | 1,050,000 | $33.30 | Buy | $34,965,000.00 | |
| March 16, 2020 | Director | 694,303 | $31.51 | Buy | $21,877,487.53 | |
| Jan. 7, 2020 | Director | 10,000 | $42.19 | Sell | $421,900.00 | |
| Dec. 12, 2019 | EVP | 105,479 | $44.46 | Sell | $4,689,596.34 | |
| Dec. 9, 2019 | CFO | 36,000 | $49.66 | Sell | $1,787,760.00 | |
| Dec. 9, 2019 | EVP | 14,521 | $50.46 | Sell | $732,729.66 | |
| Dec. 5, 2019 | CEO | 150,000 | $52.34 | Sell | $7,851,000.00 | |
| Nov. 19, 2019 | President | 2,160 | $46.41 | Sell | $100,245.60 | |
| Oct. 15, 2019 | Insider | 147 | $39.65 | Sell | $5,828.55 | |
| Oct. 15, 2019 | EVP | 877 | $39.65 | Sell | $34,773.05 | |
| Oct. 15, 2019 | President | 1,031 | $39.65 | Sell | $40,879.15 | |
| Oct. 15, 2019 | CEO | 2,983 | $39.65 | Sell | $118,275.95 | |
| Oct. 9, 2019 | CEO | 29,792 | $40.00 | Sell | $1,191,680.00 | |
| Sept. 20, 2019 | Director | 1,562,500 | $40.00 | Buy | $62,500,000.00 | |
| Sept. 11, 2019 | Insider | 4,645 | $41.18 | Sell | $191,281.10 | |
| Sept. 9, 2019 | Director | 30,000 | $37.80 | Sell | $1,134,000.00 | |
| Sept. 9, 2019 | Insider | 28,467 | $39.49 | Sell | $1,124,161.83 | |
| Jan. 9, 2019 | Director | 10,000 | $20.00 | Sell | $200,000.00 | |
| Nov. 30, 2018 | Director | 11,764,705 | $17.00 | Buy | $199,999,985.00 | |
| Sept. 20, 2018 | Director | 1,210,776 | $18.70 | Buy | $22,641,511.20 | |
| March 1, 2018 | Director | 7,000 | $23.91 | Buy | $167,370.00 | |
| Jan. 29, 2018 | EVP | 36,558 | $32.39 | Sell | $1,184,113.62 | |
| Jan. 2, 2018 | EVP | 74,321 | $30.14 | Sell | $2,240,034.94 | |
| Jan. 2, 2018 | Director | 25,000 | $30.06 | Sell | $751,500.00 | |
| Oct. 5, 2017 | EVP | 37,500 | $40.91 | Sell | $1,534,125.00 | |
| Aug. 30, 2017 | EVP | 26,507 | $34.87 | Sell | $924,299.09 | |
| Aug. 9, 2017 | EVP | 14,322 | $34.88 | Sell | $499,551.36 | |
| July 20, 2017 | EVP | 38,097 | $30.00 | Sell | $1,142,910.00 | |
| June 22, 2017 | EVP | 1,903 | $30.00 | Sell | $57,090.00 |
Insiders are both buying and selling ACADIA Pharmaceuticals Inc stock.
The insider traders at ACADIA Pharmaceuticals Inc are: Stephen Davis, Mark C Schneyer, James Kihara, Srdjan R Stankovic, Brendan Teehan, Glenn Baity, Uli Hacksell, Austin D Kim, Bros. Advisors Lp Baker, Laura Brege, Michael J Yang, Elena Ridloff, Torsten Rasmussen, William Mcdowall Wells, Eric Alejandro Miller, Austin D. Kim, Mary Ann Gray, James M Daly, Michael T Borer, Roger Mills, Felix Baker, Elizabeth A Garofalo, Thomas Aasen, Thomas H Aasen, Daniel B Soland, Leslie L Iversen, Leslie L. Iversen, Lester Ph Kaplan, L.P. 14159, Jennifer J Rhodes, Srdjan R. Stankovic, Edmund Harrigan, Michael J. Yang, and Terrence O. Moore
The most active insider trader at ACADIA Pharmaceuticals Inc is Stephen Davis with 26 trades.
Stephen Davis has sold the most ACADIA Pharmaceuticals Inc stock with a total value of $23,353,349.94.
Bros. Advisors Lp Baker has bought the most ACADIA Pharmaceuticals Inc stock with a total value of $449,849,410.39.
The most recent insider trade for ACADIA Pharmaceuticals Inc was on Feb. 9, 2026.
The single biggest insider buy for ACADIA Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $199,999,985.00 on Nov. 30, 2018.
The single biggest insider sell for ACADIA Pharmaceuticals Inc was from Stephen Davis with a total value of $7,851,000.00 on Dec. 5, 2019.